GSK stock heads into the open after a 0.39% gain

At the close on September 9, 2026, GSK stock finished at 1,803.50 pence on the London Stock Exchange, up 0.39 percent, while the FTSE 100 fell 1.31 percent. Today, investors watch GSK stock after Royal Bank of Canada started coverage with a sector perform rating.

GSK stock closed at 1,803.50 pence on the London Stock Exchange on September 9, 2026, marking a 0.39% gain for the session. Per London closing data, this move contrasted with a broader decline in the FTSE 100 index on the same date.

September 9, 2026 in numbers

GSK plc (ISIN GB0009252882) ended trading at 1,803.50 pence on the London Stock Exchange on September 9, 2026, up 0.39% from the prior close, according to the London market wrap. As London Stock Exchange data showed, the FTSE 100 closed lower on September 9, 2026, with GSK shares edging higher despite the index decline. A separate broker report noted that Royal Bank of Canada initiated coverage of GSK with a sector perform rating and a price target of 1,975 pence, providing a reference point for the shares during the latest session, as Morningstar reported on September 9, 2026.

FTSE 100 performance provided a clear comparison for GSK on September 9, 2026. According to a market report, the FTSE 100 closed at 10,670.06 points after a 1.31% drop on that date, highlighting that GSK’s modest gain outpaced the broader index decline, as Infobae reported on September 9, 2026. Session data indicated selling pressure across the index, while GSK’s closing level near 1,803.50 pence left the shares above their recent 1,796.50 pence close from September 8, 2026, when they had fallen 2.23% on the day, as described in a price wrap for that earlier session by Ad-hoc-news.

Today’s focus for GSK

Today, GSK heads into the open with attention on the fresh analyst coverage from Royal Bank of Canada. As MarketBeat reported on September 9, 2026, RBC initiated coverage of GSK with a sector perform rating and a 1,975 pence price target, framing expectations for the stock around that level ahead of today’s session. Broader market context also remains relevant, with earlier reports describing pressure on UK equities as Brent crude prices climbed toward 100 US dollars a barrel on September 9, 2026, contributing to the FTSE 100 decline noted in the London close coverage by London Stock Exchange, which may continue to shape sentiment around UK stocks including GSK today.